Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2023 07:45 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Enters into Worldwide Exclusive Agreement with Lawson Health Research Institute to Develop and Commercialize a Novel Long COVID Rapid Test

Potential world-first patented biomarker for long COVID Evaluating diagnostic companion with Bucillamine for long COVID TORONTO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd....
October 30, 2023 08:30 ET | Source: Dyadic International, Inc.

Dyadic to Present at Industry Events in November

Dyadic to Present at Industry Events in November
October 05, 2023 08:30 ET | Source: Dyadic International, Inc.

Dyadic’s C1 Platform Selected by the Vaccine and Immunotherapy Center (“VIC”) at Massachusetts General Hospital as Part of VIC’s $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic Vaccines for Infectious Diseases

JUPITER, Fla., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
September 18, 2023 16:16 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharma Withdraws COVID Phase IIB IND, Will Resubmit Pending Assessment of Ability to Meet FDA Requirements

Prompted by advice from FDA regarding study design, 60P Australia Pty Ltd, a majority-owned subsidiary of 60 Degrees Pharmaceuticals, has withdrawn its IND for ACLR8-LR, a Phase IIB study of the use...
September 18, 2023 11:40 ET | Source: Straits Research

Personal Hygiene Market Size is projected to reach USD 720 Billion by 2030, growing at a CAGR of 3.6%: Straits Research

New York, United States, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Personal hygiene is maintaining one's health and hygiene to prevent infectious diseases, fungi, and other illnesses. Regular hand washing,...
September 15, 2023 15:23 ET | Source: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research partners with 95 Walgreens stores in Alabama to raise awareness of sarcoidosis and the importance of all impacted by heart and lung disease to get vaccinated

CHICAGO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Beginning September 16th, Walgreens, a pharmacy and retail leader who plays a critical role in the U.S. healthcare system by providing a wide range of...
September 13, 2023 10:57 ET | Source: Association of American Physicians and Surgeons

Mask Mandates Violate the Right to Informed Consent and Should Not Return, States the Association of American Physicians and Surgeons (AAPS)

TUCSON, Ariz., Sept. 13, 2023 (GLOBE NEWSWIRE) -- As masking mandates are being reintroduced in schools and medical facilities, the Association of American Physicians and Surgeons (AAPS) issued a...
August 30, 2023 11:28 ET | Source: Association of American Physicians and Surgeons

Ways to Counteract COVID Spike Protein Discussed in Journal of American Physicians and Surgeons (AAPS)

TUCSON, Ariz., Aug. 30, 2023 (GLOBE NEWSWIRE) -- The SARS-CoV-2 spike protein found in cells and tissues after COVID-19 respiratory illness and COVID-19 vaccination, which is thought to account for...
August 17, 2023 10:00 ET | Source: Rationalstat LLC

[Market Study] Global Covid Testing Kit Market is expected to hit US$ 52.2 billion by 2028, registering a substantial CAGR of over 19.8%, market report by RationalStat

Wilmington, Delaware, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Market Scope and Report Overview Organizations that are driving market expansion have been making more developments. For instance, in...
August 15, 2023 07:31 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharmaceuticals Registers ACLR8-LR, a Phase IIB Study of Tafenoquine for Treatment of COVID-19, on ClinicalTrials.gov

ACLR8-LR, a double-blind, randomized, placebo-controlled Phase IIB study to determine efficacy of the ARAKODA® regimen of tafenoquine in COVID-19 patients with mild-moderate symptoms and low risk of...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right